Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function

Clinical trial NCT07309393 · RECRUITING

Trial details

NCT number: NCT07309393
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Residual Neuromuscular Block

Start date: 2025-12-30
Primary completion: 2026-09-25
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.